|1.||Haznedaroglu, Ibrahim C: 19 articles (06/2015 - 01/2009)|
|2.||Kurt, Mevlut: 15 articles (06/2015 - 08/2008)|
|3.||Beyazit, Yavuz: 9 articles (05/2014 - 12/2010)|
|4.||Kekilli, Murat: 9 articles (01/2013 - 01/2009)|
|5.||Purnak, Tugrul: 7 articles (05/2014 - 03/2010)|
|6.||Ozaslan, Ersan: 7 articles (03/2011 - 03/2010)|
|7.||Haznedaroglu, Ibrahim Celalettin: 7 articles (01/2011 - 08/2008)|
|8.||Shorbagi, Ali: 5 articles (07/2012 - 01/2009)|
|9.||Akdogan, Meral: 5 articles (08/2010 - 08/2008)|
|10.||Bilgili, Hasan: 4 articles (06/2015 - 01/2009)|
01/01/2011 - "In our study, we investigated the efficacy of Ankaferd Blood Stopper in the prevention of air leakage in the lung and bleeding. "
03/01/2010 - "The aim of this study was to retrospectively assess the haemostatic efficacy of the endoscopic topical use of Ankaferd Blood Stopper (ABS) in the setting of neoplastic GI bleeding. "
05/01/2015 - "Hemostatic efficacy of a traditional medicinal plant extract (Ankaferd Blood Stopper) in bleeding control."
12/16/2012 - "To prospectively assess the hemostatic efficacy of the endoscopic topical use of ankaferd blood stopper (ABS) in active non-variceal upper gastrointestinal system (GIS) bleeding. "
12/16/2012 - "Efficacy of ankaferd blood stopper application on non-variceal upper gastrointestinal bleeding."
10/01/2011 - "The aim of this study was to assess the hemostatic efficacy of Ankaferd Blood Stopper (ABS) in an experimental epistaxis model and to determine the histopathologic alterations with topical ABS application. "
11/01/2011 - "Persistent nasal bleeding due to nasal CPAP application in 2 premature newborns successfully treated with topical "Ankaferd blood stopper"."
09/01/2010 - "Prospective, randomized, controlled clinical trial of Ankaferd Blood Stopper in patients with acute anterior epistaxis."
09/01/2010 - "This is a study evaluating the efficacy of Ankaferd Blood Stopper (ABS) as a hemostatic agent compared to hemostasis by phenylephrine in patients with anterior epistaxis. "
11/01/2011 - "The efficacy of Ankaferd Blood Stopper in heparin-induced hemostatic abnormality in a rat epistaxis model."
|4.||Hemorrhagic Disorders (Hemorrhagic Diathesis)
|5.||Wounds and Injuries (Trauma)
01/01/2014 - "To conduct a histopathological evaluation of the effects of Ankaferd Blood Stopper (ABS) on healing wounds in a rabbit skin incision model. "
01/01/2014 - "New hemostatic agent: the effect of Ankaferd Blood Stopper on healing wounds in experimental skin incision model."
01/01/2013 - "Medicinal plant extract (Ankaferd Blood Stopper) application in deep tissue injuries in rats: histopathological investigation of the effect on regional and systemic tissues."
04/01/2012 - "Beneficial effects of Ankaferd Blood Stopper on caustic esophageal injuries: an experimental model."
08/01/2010 - "Ankaferd Blood Stopper could hold a great premise for clinical management of surgery bleedings as well as immediate cessation of bleeding on external injuries based on upcoming clinical trials."
|2.||Plant Preparations (Preparation, Plant)
|8.||Aspirin (Acetylsalicylic Acid)
|10.||Fibrin Tissue Adhesive (Fibrin Sealant)
|2.||Tooth Extraction (Tooth Extractions)